EVFM should close above $1 today.

20 day ma crossed the 50-day. Very bullish.

If vaping causes GERD SLDX is going to have an even bigger market. It seems like everyone vapes. https://www.medicalnewstoday.com/articles/vaping-vs-smoking#summary

EVFM is under attack by shorts. One of the worst and most notorious short sellers. They're struggling. EVFM has great numbers and the potential for FDA approval for STDs. I think the stock is going a lot higher from here. jmo

Sand Diego Business Journal article on EVFM. Just out. https://www.sdbj.com/news/2022/jul/11/evofems-wild-ride/

100% agree. Right down to the BS hit piece. Don't forget the stock was trading around these levels after they did the reverse, but before the offering. I'd imagine most of the warrant holders exercised, so EVFM is probably sitting on $30+ million in cash, which is close to $1 a share, EVFM is going higher. Sabby and the other shorts can't stop it. .

Andy Goram: Rangers legend dies aged 58 after esophageal cancer diagnosis

https://www.nationalworld.com/sport/football/andy-goram-dies-rangers-legend-cancer-cause-death-3754085

Which one? TPIA or Ei Ventures?

Stella Diagnostics and Mayo Clinic presented data on the utility of the STLA101 Test for esophageal cancer staging at the 2022 American Gastroenterological Association Digestive Disease Week Conference in May. This is is the world's largest gathering of professionals in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Pictured below L to R are Mayo Clinic’s Dr Chris Hartley, Stella Diagnostics co-founder and board member Fred Zaino, and Dr Sumeet Mittal.

Chief Scientific Officer and Co-founder of Stella Diagnostics, Joe Abdo, PhD, co-authored this informative peer-reviewed article with key opinion leaders in oncology. The article appeared in the Journal of Gastrointestinal Oncology. I like investing in a company led by someone who is smarter than I am. Current state of prognostication, therapy and prospective innovations for Barrett’s-related esophageal adenocarcinoma: a literature review

About 20,640 U.S. adults will be diagnosed with esophageal cancer this year, according to estimates from the American Cancer Society (ACS). SLDX will be in big demand. https://www.washingtonpost.com/health/2022/05/31/esophageal-cancer-rising-middle-age/

Video of CBNT's Patriot Glass Solutions’ demo yesterday in Los Angeles.

Cbond's ballistic resistant system could really put this little company on the map.

I've bought some AMPH at $31. Great products and decent numbers. Hoping for a move back up to the low $40's.

I've followed PLUG and traded in and out of it over the past year. I'm not impressed with management. I believe FCEL has a much better management team.

I'm glad you're not managing my family's money! EVFM will do $30 to $35 million this year, and they have cash to execute. Three analysts say $2 to $3.50. I think I'll go with the analysts.

I did too. I spoke with the company and the merger with Ei is still on.

You're sadly mistaken. Before Stella Diagnostics merged with the shell, the shell was reversed 1 for every 50,000. Anyone involved with the old company is long gone. The bulk of SLDX shares are owned by management and the Board of Directors. The Board is made up of fund managers and Wall Street veterans, including Peter Cohen the ex-CEO of Shearson Lehman, American Express, and Cowen. https://www.stelladx.com/team/board-of-directors

Good point!

Anyone know why they have a million plus users on a waiting list?

Maybe I bought your shares? No dilution. The share count hasn't changed in months. https://www.otcmarkets.com/stock/LCLP/security They said this pn the call last week and filed the transcript with the SEC. They also said why they were late on thir filings.

NUGL is on fire! NUGL Inc. Closes Acquisition Of Kaya LLC, One Of Jamaica’s Leading, Vertically Integrated Medical Cannabis Companies
https://finance.yahoo.com/news/nugl-inc-closes-acquisition-kaya-123000383.html

Is anyone else new here? Coming in because they found out about Stella Diagnostics?

Big Apple doesn't have anything to do with this company. Someone bought the old shell and that's how SLDX came public. Stella Diagnostics is going to be a big winner. They're able to detect esophegeal disease and cancer years earlier than anyone. Look at the Board of Directors https://www.stelladx.com/team/board-of-directors

That guy Peter Cohen was CEO and Chairmana of Shearson Lehman American Express back in the 1990's. The rest of the board are hedge fund managers. I think it's a winner.

I was a buyer at the end of the day today. If I'm wrong, maybe I'll buy some more, or maybe I'll cut my losses. Nothing goes straight down and Life Clips has a lot of growth with Belfrics. For those saying Grinberg is bad, Praveen was broke and couldn't raise the money to get Belfrics going. Grinberg raised it through Life Clips. Also, Grinberg invested millions into this company five years ago, so he paid for all of his stock. If you don't like him, or how he's running the company, sell and find another stock you like. It's still the same company and now the stock price is lower.

He's right. You're lucky you even received a reply. It's your responsibility to take small losses, if you can't afford big ones. Why would you send a public company an email like that?

Long and Strong $TPIA!

Not a scam. Ei.Ventures raised $25 million in a Reg A https://www.ei.ventures. They sent an email to all of their Reg A subscribers and said they were cutting it off their Reg A on March 22, which they did. Ei.Ventures also said they would be moving ahead with the merger with TPIA. Here's a recent video discussing it.

The stock price is creeping up. Probably not enough people know about what's going on with acquiring Kaya herb house?

Looks like some stock still ocming out after financing. Once it is gone we will see higher prices. Ketadash is revenue generating.

Looks like some stock still ocming out after financing. Once it is gone we will see higher prices. Ketadash is revenue generating.

Looks like some stock still ocming out after financing. Once it is gone we will see higher prices. Ketadash is revenue generating.

This looks like a solid company. https://kayaherbhouse.com Old CJ really came through. Very exciting.

I'm adding here. QLGN has had no news and nothing but negativity. I've done dumber things.

I do not have a few hundred K right now. I'm thinking I have a little more time to add.

One day soon QSAM is going to get noticed, and I am going to be very happy I accumulated a few hundred thousand shares.

Attaboy! Me too.

The long term trend on the chart is up. The 50-day moving average is $0.0252 and the 200-day is $0.0124. There is plenty of steam left in RGBP. The MACD and RSI both show the stock is deep in oversold territory. Not only that, but the company is fully reporting with the SEC. https://www.sec.gov/edgar/browse/?CIK=1589150&owner=exclude

The only question is who has the balls to step up to the plate and be a buyer when the stock is down?

RGBP One Year Chart

Theere are two or three sellers holding QSAM down. Once we get some more volume and people buying the stock will run. JMO

I'm with you! QSAM will get bought out somewhere along the line.